Cargando…

Steroid Receptor Co-Activators Regulate Metabolic Kinases to Drive Therapy Resistant ER+ Breast Cancer

Recurrence of metastatic breast cancer stemming from acquired endocrine and chemotherapy resistance remains a health burden for women with luminal (ER+) breast cancer. Disseminated ER+ tumor cells can remain viable but quiescent for years to decades. Contributing factors to metastatic spread include...

Descripción completa

Detalles Bibliográficos
Autores principales:	Truong, Thu Ha, Benner, Elizabeth A, Hagen, Kyla M, Temiz, Nuri A, Kerkvliet, Carlos Perez, Wang, Ying, Cortes-Sanchez, Emilio, Yang, Chieh-Hsiang, Pengo, Thomas, Guillen, Katrin P, Welm, Bryan E, Telang, Sucheta, Lange, Carol A, Ostrander, Julie Hanson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089334/ http://dx.doi.org/10.1210/jendso/bvab048.2111

Ejemplares similares

OR16-2 Steroid Receptor Co-Activator Complexes Regulate Metabolic PFKFB Enzymes to Drive Therapy Resistant ER+ Breast Cancer
por: Benner, Elizabeth, et al.
Publicado: (2022)

PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer
por: Truong, Thu H., et al.
Publicado: (2021)

OR05-04 Steroid Receptor Co-Activators Complexes Cooperate with Progesterone Receptors (PR) to Reprogram Metabolic Pathways that Drive Therapy Resistant Populations in ER+ Breast Cancer
por: Truong, Thu H, et al.
Publicado: (2020)

OR34-1 Regulation of Breast Cancer Stem Cells by Nuclear Receptor Co-Regulatory Proteins
por: Ostrander, Julie, et al.
Publicado: (2019)

Targeting steroid receptor co-activators to inhibit breast cancer stem cells
por: Truong, Thu H., et al.
Publicado: (2018)

THU556 Targeting Breast Cancer Stem Cells With Oncolytic Virus
por: Roman Ortiz, Natasha Ivelisse, et al.
Publicado: (2023)

THU477 Drivers Of Estrogen Induced Invasive Lobular Carcinoma
por: Ufondu, Chinasa, et al.
Publicado: (2023)

SAT-133 Breast Tumor Kinase (Brk/PTK6) Mediates Triple Negative Breast Cancer Cell Migration and Taxol Resistance via SH2 Domain-Dependent Activation of RhoA and AhR
por: Dwyer, Amy Renee, et al.
Publicado: (2020)

THU559 3D Immuno-smFISH Reveals ER-responsive Cells At The Single-cell Level In ER(+) Breast Cancer
por: Kammel, Laura G, et al.
Publicado: (2023)

Simultaneous inhibition of the estrogen receptor and 6-phosphofructo-2-kinase (PFKFB3) for the treatment of ER+ breast cancer
por: Imbert-Fernandez, Yoannis, et al.
Publicado: (2014)

SUN-931 Characterization of an Ovarian Steroid Cell Tumor in a VHL Patient
por: Nocito, Marta Claudia, et al.
Publicado: (2020)

ODP647 Nuclear ERα and NAMPT Crosstalk in Metastatic Breast Tumors
por: Mogol, Ayca, et al.
Publicado: (2022)

ODP539 AIPB is a Biomarker for ER+/PR+/Her2- Breast Cancers
por: Cubbedge, Chandler, et al.
Publicado: (2022)

SAT-119 Targeting Glutamate Metabolism and Signaling in ER+, Endocrine Therapy-Resistant Breast Cancer
por: Olukoya, Ayodeji O, et al.
Publicado: (2020)

OR16-5 Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer
por: Bahnassy, Shaymaa, et al.
Publicado: (2022)

MON-312 Biochemical Basis of Steroid Hormones Action on Human Melanoma Cell Growth In-Vitro and Its Clinical Implication
por: Ramaraj, Pandurangan
Publicado: (2019)

OR16-06 A Novel Pathway Controlling Anticancer Drug Induced Immunogenic Necrosis In ERα Positive Cancer Cells
por: Zhu, Junyao, et al.
Publicado: (2023)

THU555 Stress Induced AIPB Expression In Triple Negative (ER-/PR-/Her2-) Breast Tumors Reduces Estradiol
por: Patrawala, Mahjabin, et al.
Publicado: (2023)

MON-337 A Case Study: Steroid and Gonadotropin Hormones Secretion Pattern in Ovarian Cancer: 10-Year Follow-Up
por: Ezeiruaku, Ferdinand
Publicado: (2019)

Thyroid Hormone and Estrogen Promote Endocrine Resistance, Proliferation, Dedifferentiation, and Cancer Stem Cells in Steroid Receptor-Positive Breast Cancers
por: Wahdan-Alaswad, Reema S, et al.
Publicado: (2021)

Breast cancer PDxO cultures for drug discovery and functional precision oncology
por: Scherer, Sandra D., et al.
Publicado: (2023)

SUN-133 Intratumoral Expression of Steroid Receptors, CD68+ Macrophages and Mdm2 in Different Molecular-Biological Types of Endometrial Cancer
por: Berstein, Lev M, et al.
Publicado: (2020)

OR34-2 SREBP1 Drives KRT80-Dependent Cytoskeletal Changes and Invasive Behaviour in Endocrine-Resistant ERα Breast Cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

OR05-05 Lethal ERα-Dependent Hyperactivation of the Unfolded Protein Response Induces Complete Regression Without Recurrence of Primary and Metastatic Breast Cancer
por: Duraki, Darjan, et al.
Publicado: (2020)

Assessment of Steroid Hormones in Both Saliva and Blood During a Phase 2 Clinical Trial for the Use of Tildacerfont in Adults With Classic Congenital Adrenal Hyperplasia
por: Keevil, Brian, et al.
Publicado: (2021)

ODP558 Steroid Receptor Coactivators Promote Non-Small Cell Lung Cancer Tumorigenesis by Inhibiting Differentiation Factors, C/EBPα and NF-κB
por: Mendelson, Carole, et al.
Publicado: (2022)

Lactoferrin: A Critical Player in Neonatal Host Defense
por: Telang, Sucheta
Publicado: (2018)

Do’s and Don’ts in Primary Aneurysmal Bone Cysts of the Proximal Femur in Children and Adolescents: Retrospective Multicenter EPOS Study of 79 Patients
por: van Geloven, Thomas P.G., et al.
Publicado: (2023)

Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer
por: Nam, Gi-Hoon, et al.
Publicado: (2021)

The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma
por: Trovik, Clement, et al.
Publicado: (2017)

Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones: A retrospective study of 93 patients
por: van der Heijden, L, et al.
Publicado: (2012)

Custom osteotomy guides for resection of a pelvic chondrosarcoma
por: Blakeney, William G, et al.
Publicado: (2014)

Giant Cell Tumor (GCT) of Capitate
por: Narayana Gowda, BS, et al.
Publicado: (2012)

Metastatic adenocarcinoma of Proximal Femur treated by Custom made Hip Prosthesis
por: Pal, Chandra Prakash, et al.
Publicado: (2012)

Surgery of non-spinal skeletal metastases in renal cell carcinoma
por: Ratasvuori, Maire, et al.
Publicado: (2016)

Osteochondroma Arising from the Thoracic Transverse Process
por: Wenyuan, Ding, et al.
Publicado: (2009)

Computer-assisted surgery in orthopedic oncology: Technique, indications, and a descriptive study of 130 cases
por: Gerbers, Jasper G, et al.
Publicado: (2014)

Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center
por: Dyrop, Heidi B, et al.
Publicado: (2014)

Pelvic irradiation does not increase the risk of hip replacement in patients with gynecological cancer: A cohort study based on 8,507 patients
por: Dybvik, Eva, et al.
Publicado: (2014)

Comparison of allograft-prosthetic composite reconstruction and modular prosthetic replacement in proximal femur bone tumors: Functional assessment by gait analysis in 20 patients
por: Benedetti, Maria Grazia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_eukof4iumot0id3prmth7cqm8i